These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8809734)

  • 1. Androgen insensitivity syndrome due to new mutations in the DNA-binding domain of the androgen receptor.
    Imasaki K; Okabe T; Murakami H; Tanaka Y; Haji M; Takayanagi R; Nawata H
    Mol Cell Endocrinol; 1996 Jun; 120(1):15-24. PubMed ID: 8809734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired nuclear translocation, nuclear matrix targeting, and intranuclear mobility of mutant androgen receptors carrying amino acid substitutions in the deoxyribonucleic acid-binding domain derived from androgen insensitivity syndrome patients.
    Kawate H; Wu Y; Ohnaka K; Tao RH; Nakamura K; Okabe T; Yanase T; Nawata H; Takayanagi R
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6162-9. PubMed ID: 16118342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
    Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
    Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene.
    Weidemann W; Linck B; Haupt H; Mentrup B; Romalo G; Stockklauser K; Brinkmann AO; Schweikert HU; Spindler KD
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):733-9. PubMed ID: 9039340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome.
    De Bellis A; Quigley CA; Marschke KB; el-Awady MK; Lane MV; Smith EP; Sar M; Wilson EM; French FS
    J Clin Endocrinol Metab; 1994 Mar; 78(3):513-22. PubMed ID: 8126121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
    Tadokoro R; Bunch T; Schwabe JW; Hughes IA; Murphy JC
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):253-60. PubMed ID: 19178528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel substitution (Leu707Arg) in exon 4 of the androgen receptor gene causes complete androgen resistance.
    Lumbroso S; Lobaccaro JM; Georget V; Leger J; Poujol N; Térouanne B; Evain-Brion D; Czernichow P; Sultan C
    J Clin Endocrinol Metab; 1996 May; 81(5):1984-8. PubMed ID: 8626869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome.
    Jääskeläinen J; Mongan NP; Harland S; Hughes IA
    Hum Mutat; 2006 Mar; 27(3):291. PubMed ID: 16470553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome.
    Nguyen D; Steinberg SV; Rouault E; Chagnon S; Gottlieb B; Pinsky L; Trifiro M; Mader S
    Mol Endocrinol; 2001 Oct; 15(10):1790-802. PubMed ID: 11579211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
    Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A point mutation in the second zinc finger of the DNA-binding domain of the androgen receptor gene causes complete androgen insensitivity in two siblings with receptor-positive androgen resistance.
    Mowszowicz I; Lee HJ; Chen HT; Mestayer C; Portois MC; Cabrol S; Mauvais-Jarvis P; Chang C
    Mol Endocrinol; 1993 Jul; 7(7):861-9. PubMed ID: 8413310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.
    Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Tilley WD; Leedman PJ; Hurley DM
    J Clin Endocrinol Metab; 1996 Jan; 81(1):236-43. PubMed ID: 8550758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L712V mutation in the androgen receptor gene causes complete androgen insensitivity syndrome due to severe loss of androgen function.
    Rajender S; Gupta NJ; Chakrabarty B; Singh L; Thangaraj K
    Steroids; 2013 Dec; 78(12-13):1288-92. PubMed ID: 24055831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two de novo mutations in the AR gene cause the complete androgen insensitivity syndrome in a pair of monozygotic twins.
    Mongan NP; Jääskeläinen J; Green K; Schwabe JW; Shimura N; Dattani M; Hughes IA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1057-61. PubMed ID: 11889162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat.
    Yarbrough WG; Quarmby VE; Simental JA; Joseph DR; Sar M; Lubahn DB; Olsen KL; French FS; Wilson EM
    J Biol Chem; 1990 May; 265(15):8893-900. PubMed ID: 2341409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain.
    Murono K; Mendonca BB; Arnhold IJ; Rigon AC; Migeon CJ; Brown TR
    Hum Mutat; 1995; 6(2):152-62. PubMed ID: 7581399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations.
    Holterhus PM; Werner R; Hoppe U; Bassler J; Korsch E; Ranke MB; Dörr HG; Hiort O
    J Mol Med (Berl); 2005 Dec; 83(12):1005-13. PubMed ID: 16283146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription activating and repressing functions of the androgen receptor are differentially influenced by mutations in the deoxyribonucleic acid-binding domain.
    Aarnisalo P; Santti H; Poukka H; Palvimo JJ; Jänne OA
    Endocrinology; 1999 Jul; 140(7):3097-105. PubMed ID: 10385402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and structural analysis of R607Q and R608K androgen receptor substitutions associated with male breast cancer.
    Poujol N; Lobaccaro JM; Chiche L; Lumbroso S; Sultan C
    Mol Cell Endocrinol; 1997 Jun; 130(1-2):43-51. PubMed ID: 9220020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance.
    Zoppi S; Marcelli M; Deslypere JP; Griffin JE; Wilson JD; McPhaul MJ
    Mol Endocrinol; 1992 Mar; 6(3):409-15. PubMed ID: 1316540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.